NR1H4 ameliorates Parkinson’s disease via inhibiting astrocyte activation and neuroinflammation in a CEBPβ/NF-κB dependent mannerJingwen Li, Nian Xiong, Xinyu Hu et al.|International Immunopharmacology|2024Cited by 13